2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Oral Session

[O1] Oral Session 1 Gastrointestinal Cancer 1(Upper GI Tract)
【E】

Thu. Feb 17, 2022 9:30 AM - 11:00 AM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair:Taroh Satoh(Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine),Chin Kensho(Outpatient Chemotherapy Department, Cancer Institute Hospital of JFCR)
Discussant:Izuma Nakayama(Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of the JFCR)

Hiroki Hara1, Taroh Satoh2, Takashi Kojima3, Satoru Motoyama4, Takahiro Tsushima5, Yu Sunakawa6, Morihito Okada7, Aiyang Tao8, Ningning Ding8, Ken Kato9 (1.Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan, 2.Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan, 3.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 4.Department of Esophageal Surgery, Akita University Hospital, Akita, Japan, 5.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan, 6.Department of Clinical Oncology, St. Marianna University School of Medicine, Kanagawa, Japan, 7.Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan, 8.BeiGene Ltd, Zhongguancun Life Science Park, Beijing, China, 9.Department of Head and Neck Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)

Shun Yamamoto1, Keisho Chin2, Masanobu Takahashi3, Shigenori Kadowaki4, Yutaro Kubota5, Yusuke Amanuma6, Morihito Okada7, Mitsuro Kanda8, Yasue Kimura9, Yuhiko Nogi10, Yuko Arimitsu11, Yuko Kitagawa12 (1.Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 2.Department of Gastroenterological Chemotherapy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3.Department of Medical Oncology, Tohoku University Hospital, 4.Department of Clinical Oncology, Aichi Cancer Center Hospital, 5.Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 6.Department of Clinical Trial Promotion, Chiba Cancer Center, 7.Department of Surgical Oncology, Hiroshima University, 8.Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 9.Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 10.Department of Oncology Medical, Bristol-Myers Squibb, 11.Department of Oncology Medical Affairs, ONO Pharmaceutical Company, 12.Department of Surgery, Keio University School of Medicine)

Kenro Tanoue1, Hirofumi Ohmura1, Kenji Tsuchihashi1, Yudai Shinohara3, Mamoru Ito1, Kyoko Yamaguchi1, Shingo Tamura2, Hozumi Shimokawa3, Taichi Isobe1, Yoshihiro Shibata5, Hiroshi Ariyama1, Risa Tanaka4, Hitoshi Kusaba1, Taito Esaki6, Kenji Mitsugi7, Koichi Akashi1, Eishi Baba8 (1.Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, 2.Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, 3.Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, 4.Department of Medical Oncology, Hamanomachi Hospital, 5.Department of Medical Oncology, Fukuoka Wajiro Hospital, 6.Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, 7.Department of Medical Oncology, Sasebo Kyosai Hospital, 8.Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University)

Nozomu Machida1, Masanori Tokunaga2, Junki Mizusawa3, Hiroshi Yabusaki4, Hirofumi Yasui5, Motohiro Hirao6, Masaya Watanabe7, Takushi Yasuda8, Takahiro Kinoshita9, Hiroshi Imamura10, Jun Hihara11, Tomoko Kataoka3, Narikazu Boku12, Takaki Yoshikawa13, Takeshi Sano14, Mitsuru Sasako15, Masanori Terashima16 (1.Department of Gastroenterology, Kanagawa Cancer Center, 2.Tokyo Medical and Dental University, Gastrointestinal Surgery, 3.Japan Clinical Oncology Group Data Center/Operations Office, 4.Niigata Cancer Center Hospital, Division of Surgery, 5.Shizuoka Cancer Center, Division of Gastrointestinal Oncology, 6.National Hospital Organization Osaka National Hospital, Department of Surgery, 7.Shizuoka General Hospital, Department of Gastroenterological Surgery, 8.Kindai University Faculty of Medicine, Department of Surgery, 9.National Cancer Center Hospital East, Department of Gastric Surgery, 10.Toyonaka Municipal Hospital, Department of Surgery, 11.Hiroshima City Asa Citizens Hospital, Department of Surgery, 12.IMS Hospital, Institute of Medical Science, University of Tokyo, Department of Medical Oncology and General Medicine, 13.National Cancer Center Hospital, Department of Gastric Surgery, 14.The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Department of Gastroenterological Surgery, 15.Yodogawa Christian Hospital, Department of Surgery, 16.Shizuoka Cancer Center, Division of Gastric Surgery)

Kensei Yamaguchi1, Ooki Akira1, Kang Yoon-Koo2, Lee Keun-Wook3, Bai Li-Yuan4, Collins Helen5, Yang Yingsi5, Mezzi Khalid5, Catenacci Daniel6, Enzinger Peter7, Wainberg Zev8 (1.Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 2.University of Seoul, South Korea, 3.Seoul National University Bundang Hospital,South Korea, 4.China Medical University, Taiwan, 5.Amgen Inc, United States, 6.University of Chicago, United States, 7.Dana Farber Cancer Institute, United States, 8.University of California, Los Angeles, United States)

Yasuhiro Sakamoto1, Yukiya Narita2, Toshihiro Misumi3, Hiroshi Matsuoka4, Hiroaki Tanioka5, Takeshi Kawakami6, Tomohiro Matsushima7, Hiroto Miwa8, Hirokazu Shoji9, Atsushi Ishiguro10, Sachio Fushida11, Kou Miura12, Takanobu Yamada13, Katsunori Shinozaki14, Takuro Mizukami15, Tomohiro Nishina16, Toshikazu Moriwaki17, Seiichiro Mitani18, Michio Nakamura19, Kei Muro2 (1.Department of Medical Oncology, Osaki Citizen Hospital, 2.Department of Clinical Oncology, Aichi Cancer Center Hospital, 3.Department of Biostatistics, Yokohama City University School of Medicine, 4.Department of Gastrointestinal Surgery School of Medicine, Fujita Health University Hospital, 5.Department of Clinical Oncology, Kawasaki Medical School, 6.Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 7.Department of Gastroenterology, Saitama Cancer Center, 8.Division of Gastroenterology and Hepatology, Hyogo College of Medicine, 9.Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 10.Department of Medical Oncology, Teine Keijinkai Hospital, 11.Department of Gastroenterological Surgery, Kanazawa University Graduate School of Medical Sciences, 12.Department of Internal Medicine, Himeji Red Cross Hospital, 13.Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 14.Division of Clinical Oncology, Hiroshima Prefectural Hospital, 15.Department of Clinical Oncology, St. Marianna University School of Medicine, 16.Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, 17.Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 18.Department of Medical Oncology, Faculty of Medicine, Kindai University, 19.Department of Gastroenterology, Sapporo City General Hospital)